Who Bears the Risk in Healthcare M&A? Impacts of AI and the One Big Beautiful Bill.

Why It Matters

The shift forces dealmakers to renegotiate risk structures, directly affecting transaction costs and post‑closing liability exposure in a heavily regulated sector.

Key Takeaways

• R&W insurers now exclude systemic billing, OBBBA metrics, and AI liabilities
• Buyers must add special indemnity escrows for uncovered regulatory and AI risks
• AI algorithm integrity, data provenance, and security need dedicated representations
• Sellers should secure third‑party bias audits and HIPAA‑compliant data for proprietary AI

Pulse Analysis

The One Big Beautiful Bill Act (OBBBA) is redefining compliance expectations for healthcare providers, especially in value‑based care reporting. As state and federal agencies tighten oversight, traditional "compliance with laws" representations have become less protective, prompting insurers to withdraw from covering systemic billing and coding exposures. This regulatory drift erodes the safety net that R&W insurance once offered, compelling acquirers to reassess how they allocate risk before a deal closes.

Simultaneously, the rapid integration of artificial‑intelligence tools into clinical workflows introduces a distinct liability class. AI algorithms can generate biased outputs, misdiagnose patients, or produce "hallucinations," exposing owners to costly malpractice and regulatory penalties. Consequently, savvy buyers now embed AI‑specific representations—covering algorithmic integrity, data provenance, and cybersecurity—directly into purchase agreements. These clauses not only clarify performance expectations but also create a contractual basis for indemnification when AI‑related failures emerge post‑closing.

Practically, the evolving risk landscape drives a two‑pronged deal‑structuring response. First, parties are establishing "special indemnity" escrow accounts to fund potential clawbacks from CMS audits or AI‑related claims that fall outside standard caps. Second, sellers are bolstering internal governance, ensuring that compliance and technology teams collaborate early to document AI development processes and secure third‑party bias audits. By embedding these safeguards, both buyers and sellers can close transactions with greater confidence, mitigating exposure that traditional insurance can no longer absorb.